|
Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults Clinical research trials and Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults. Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults clinical trial. Subjects typically recieve the finest healthcare available for their Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults  Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults
Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults
For Condition: Attention Deficit Disorder
Status: Completed
Sponsor(s): Sponsor Name Pending ,
Synopsis: A placebo controlled study evaulating the efficacy and safety of medication in adults with Attention-Deficit Hyperactivity Disorder (ADHD)
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/60 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: (Patients must meet the following criteria in order to be eligible for this study.) - Patient must be diagnosed with ADHD Exclusion Criteria: (Patients cannot meet the following criteria in order to be eligible for this study.) - Patient has a current or past history of seizure disorder, brain injury, anorexia nervosa or bulimia. - Patient has a current diagnosis of Major Depressive Disorder (MDD). - Patient has a current primary diagnosis of, or received treatment for, Panic Disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD) or Acute Stress Disorder within the previous 12 months, - Patient has a lifetime diagnosis of bipolar disorder, schizophrenia or other psychotic disorders. - Patient has a positive urine test at screening for presence of illicit drugs or alcohol abuse during the past 12 months.
Total Enrollment:
Location and Contact Information:
Study Site
Spring Valley, California, 91978
United States
Study Site
Omaha, Nebraska, 68105
United States
Study Site
Boston, Massachusetts, 02114
United States
Study Site
Northridge, California, 91324
United States
Study Site
Phoenix, Arizona, 85051
United States
Study Site
Portland, Oregon, 97209
United States
Study Site
Houston, Texas, 77007
United States
Study Site
Lafayette, California, 94549
United States
Study Site
Salt Lake City, Utah, 84132
United States
Study Site
Burlington, Vermont, 05405
United States
Study Site
Worcester, Massachusetts, 01655
United States
Study Site
Rockville, Maryland, 20852
United States
Study Site
Seattle, Washington, 98104
United States
Study Site
Chapel Hill, North Carolina, 27514
United States
Study Site
Beachwood, Ohio, 44122
United States
Study Site
Woodstock, Vermont, 05091
United States
Study Site
West Palm Beach, Florida, 33407
United States
Study Site
Paducah, Kentucky, 42003
United States
Study Site
Bellaire, Texas, 77401
United States
Study Site
Cincinnati, Ohio, 45267-0559
United States
Study Site
Chula Vista, California, 91910
United States
Additional Information:
Study ID Numbers: AK130934;
Study Start Date:
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00048360
Other Attention Deficit Disorder Studies:
1. Attention Deficit Disorder and Exposure to Lead
2. Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults
Related Studies:
Other Attention Deficit Disorder Clinical Trials
Other Arizona Clinical Trials
Other Phoenix Clinical Trials
Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults
|
|
|
|
|
|
|
|
